Prediction Model for Lateral Lymph Node Metastasis
- Conditions
- Rectal Cancer
- Interventions
- Procedure: lateral lymph node dissection
- Registration Number
- NCT04635488
- Lead Sponsor
- West China Hospital
- Brief Summary
Mid to low-lying rectal cancer patient with enlarged lateral lymph node befor treatment and receiving lateral lymph node dissection would be enrolled. Radiomics parameters of lateral lymph nodes would be extracted by expert software. Then a part of the nodes would be used as the training set to build the prediction model, and the another part nodes would be used as the validation set.
- Detailed Description
After performing lateral lymph node dissection for the enrolled patients, we would find the targeted lateral node which was matched with the enlarged one in imaging from the specimen. Then the nodes would be send for pathological examination. Then we would extract the radiomics parameters of the nodes from the pretreatment CT and MRI with ITK-SNAP software. According to the pathological status, lymph nodes and corresponding radiomics parameters would be divided into positive and negative groups. Then significant parameters would be selected by R software. Then the prediction model with nomogram would be developed. 70% nodes would be used for for model development and the other 30% would be used for validation.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- middle to low-lying rectal adenocarcinoma patients with enlarged lateral lymph node ≥5mm for short diameter in CT and/or MRI
- other kind of rectal tumor including neuroendocrine and malignant.
- high location rectal cancer.
- recurrent rectal cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Trainning group lateral lymph node dissection 70% of the whole participants would be randomly divided into the training group to build the predicition model. validation group lateral lymph node dissection 30% of the whole participant would be divided into the validation group to validate the model
- Primary Outcome Measures
Name Time Method metastasis rate of lateral lymph node 2020.1-2022.12.31
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Guoxue Road 37#,West China Hospital
🇨🇳Chengdu, Sichuan, China